SCHEMBL4906725

SCHEMBL4906725

CCN(c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 9/20 0.59
HTT P42858 4/20 0.55
LMNA P02545 3/20 0.55
TSHR P16473 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HDAC3 O15379 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
POLB P06746 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
HPGD P15428 2/20 0.49
ALDH1A1 P00352 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MAPT P10636 1/20 0.48
PTGER1 P34995 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904215 0.89 MEN1 (0.61) RORCHTTLMNATSHRSMN1; SMN2
SCHEMBL4902866 0.86 HDAC8 (0.56) RORCHTTLMNASMN1; SMN2HDAC3
SCHEMBL4894519 0.86 HDAC8 (0.52) RORCLMNATSHRHDAC3HDAC11
SCHEMBL4906502 0.84 HDAC8 (0.50) RORCLMNATSHRSMN1; SMN2HDAC3
SCHEMBL19084636 0.82 HDAC8 (0.66) RORCHTTLMNATSHRSMN1; SMN2
SCHEMBL4895884 0.82 HDAC8 (0.48) RORCSMN1; SMN2HDAC3HDAC11HDAC8
SCHEMBL4905920 0.81 HDAC8 (0.54) RORCHTTLMNASMN1; SMN2HDAC3
SCHEMBL4899758 0.80 MMP2 (0.49) RORCLMNASMN1; SMN2HDAC3HDAC11
SCHEMBL4905784 0.80 LMNA (0.47) LMNATSHRSMN1; SMN2POLBMEN1
SCHEMBL4902733 0.79 ESR1 (0.60) LMNATSHRSMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD RORC 82/4885HTT 711/4885LMNA 317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD RORC 87/4885HTT 696/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.